Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer.

Cancer Chemother Pharmacol

Medizinische Klinik III-Haematology, Oncology and Transfusion Medicine, Charité-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Germany.

Published: August 2004